NEW YORK, June 19, 2017 /PRNewswire/ -- Highlights
· The global
male infertility market is expected to reach USD 4.7 billion by 2025, according to a new
report by Grand View Research, Inc.
· Globally,
increasing infertility in male and advancements in diagnostic tests
have been major factors driving the market growth.
· In addition,
growing consciousness regarding factors causing male infertility
and Assisted Reproductive Technology (ART) has led to increased
adoption of treatment.
· In the U.S.,
one third of infertility cases are due to female factor, one third
due to male factors, and remaining one third are unexplained.
· DNA
fragmentation technique was the largest segment in male infertility
tests market in 2016 and is expected to maintain its dominance
during the forecast period due to rapid growth in next few
years.
· High cost and
increasing adoption in developed countries due to higher
sensitivity and reliable analysis of sperm DNA integrity are the
key factors for its dominance.
The global male infertility market is expected to reach
USD 4.7 billion by 2025, according to
a new report by Grand View Research, Inc. Globally, increasing
infertility in male and advancements in diagnostic tests have been
major factors driving the market growth. In addition, growing
consciousness regarding factors causing male infertility and
Assisted Reproductive Technology (ART) has led to increased
adoption of treatment.
Furthermore, increasing aging population, rising obesity, and other
lifestyle-associated diseases causing infertility are likely to
boost the market during the forecast period. In the U.S., one third
of infertility cases are due to female factor, one third due to
male factors, and remaining one third are unexplained.
DNA fragmentation technique was the largest segment in male
infertility tests market in 2016 and is expected to maintain its
dominance during the forecast period due to rapid growth in next
few years. High cost and increasing adoption in developed countries
due to higher sensitivity and reliable analysis of sperm DNA
integrity are the key factors for its dominance.
In 2016, ART segment dominated in the treatment market due to high
success rate. In Vitro Fertilization and Intracytoplasmic Sperm
Injection (ICSI) are the major ARTs used. Medications include
corticosteroids and hormonal therapy; however, they are effective
in very few cases. Hence, low demand, less adherence, and lower
cost as compared to ART are likely to slow the growth of the
medication market.
Further Key Findings From the Report Suggest:
• Rising demand of ARTs across the globe is expected to propel
growth at the fastest rate from 2017 to 2025
• DNA fragmentation technique for the testing of male infertility
dominated in 2016 and is estimated to generate revenue at a rapid
rate over the forecast period.
• Oxidative stress analysis is another method gaining popularity
due to accurate determination of reactive oxygen species. The test
accounted second largest share in the testing market.
• The Europe market was the
largest in 2016 and is expected to maintain its dominance during
forecast period due to higher awareness, strong diagnosis rate, and
high adoption of costlier treatment.
• The industry in Asia Pacific is
projected to witness substantial growth over the next decade owing
to growing investment by several clinics and pharmaceutical
companies in the region, and increasing healthcare expenditure.
• Some key players include EMD Sereno, Inc.; Aytu BioScience, Inc.;
Bayer Healthcare; Cadila Healthcare Ltd.; Intas Pharmaceuticals
Ltd.; Halotech DNA SL; SCSA diagnostics, Inc.; and Andrology
Solutions. However, EMD Sereno, Inc. currently dominates the male
infertility market.
Read the full report:
http://www.reportlinker.com/p04946461/Male-Infertility-Market-Analysis-By-Test-DNA-Fragmentation-Technique-Oxidative-Stress-Analysis-Microscopic-Examination-Sperm-Agglutination-Sperm-Penetration-Assay-By-Treatment-And-Segment-Forecasts.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/male-infertility-market-is-expected-to-reach-usd-47-billion-by-2025-300476049.html
SOURCE Reportlinker